Cargando…

The Necessity of Dissection of No. 14 Lymph Nodes to Patients With Pancreatic Ductal Adenocarcinoma Based on the Embryonic Development of the Head of the Pancreas

Objectives: Pancreaticoduodenectomy (PD) followed by lymphadenectomy is performed for patients with pancreatic ductal adenocarcinoma (PDAC) located in the head of the pancreas. Because the head of the pancreas could be divided into dorsal or ventral primordium in relation to embryonic development, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Lihan, Xie, Junjie, Xu, Zhiwei, Deng, Xiaxing, Chen, Hao, Peng, Chenghong, Li, Hongwei, Chai, Weimin, Xie, Jing, Wang, Weishen, Shen, Baiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433687/
https://www.ncbi.nlm.nih.gov/pubmed/32850429
http://dx.doi.org/10.3389/fonc.2020.01343
_version_ 1783572005264556032
author Qian, Lihan
Xie, Junjie
Xu, Zhiwei
Deng, Xiaxing
Chen, Hao
Peng, Chenghong
Li, Hongwei
Chai, Weimin
Xie, Jing
Wang, Weishen
Shen, Baiyong
author_facet Qian, Lihan
Xie, Junjie
Xu, Zhiwei
Deng, Xiaxing
Chen, Hao
Peng, Chenghong
Li, Hongwei
Chai, Weimin
Xie, Jing
Wang, Weishen
Shen, Baiyong
author_sort Qian, Lihan
collection PubMed
description Objectives: Pancreaticoduodenectomy (PD) followed by lymphadenectomy is performed for patients with pancreatic ductal adenocarcinoma (PDAC) located in the head of the pancreas. Because the head of the pancreas could be divided into dorsal or ventral primordium in relation to embryonic development, the metastasis of lymph node (LN) may differ. In this retrospective study, we evaluated the impact of extended or standard LN dissection for PDAC located in ventral or dorsal primordia of the pancreatic head. Methods: From February 2016 to November 2018, 178 patients who underwent PD for PDAC were enrolled at the Pancreatic Disease Center, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University. According to the tumor location and the range of LN dissection, all patients were divided into three groups: ventral primordium with extended lymphadenectomy (VE group), ventral primordium with standard lymphadenectomy (VS group), and dorsal primordium with extended lymphadenectomy (DE group). Clinical and pathological features were retrospectively analyzed as were the long-term survival outcomes. Results: More patients in the VE group were detected with metastasis in the lymph nodes around the superior mesenteric artery (LN14) than those in the DE group (LN along the right side of the superior mesenteric artery, LN14ab): 22.9 vs. 5.9%, p = 0.005; (LN along the left side of the superior mesenteric artery, LN14cd): 10.0 vs. 0.0%, p = 0.022. LN14 was involved in more patients in the VE group than in the VS group (22.9 vs. 5.0%, p = 0.015). For IIb-stage patients in the VE group, the overall survival time (18.3 vs. 9.3 months, p < 0.001) and disease-free survival time (12.2 vs. 5.1 months, p = 0.045) were longer in those with LN14cd (–) than those with LN14cd (+). Conclusion: This study suggested that patients with PDAC located in the ventral head of the pancreas had higher risk of LN14 involvement compared with those at dorsal. Thus, a thorough dissection of LN14 in PDAC located in the ventral head of the pancreas is recommended to optimize the regional extended lymphadenectomy.
format Online
Article
Text
id pubmed-7433687
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74336872020-08-25 The Necessity of Dissection of No. 14 Lymph Nodes to Patients With Pancreatic Ductal Adenocarcinoma Based on the Embryonic Development of the Head of the Pancreas Qian, Lihan Xie, Junjie Xu, Zhiwei Deng, Xiaxing Chen, Hao Peng, Chenghong Li, Hongwei Chai, Weimin Xie, Jing Wang, Weishen Shen, Baiyong Front Oncol Oncology Objectives: Pancreaticoduodenectomy (PD) followed by lymphadenectomy is performed for patients with pancreatic ductal adenocarcinoma (PDAC) located in the head of the pancreas. Because the head of the pancreas could be divided into dorsal or ventral primordium in relation to embryonic development, the metastasis of lymph node (LN) may differ. In this retrospective study, we evaluated the impact of extended or standard LN dissection for PDAC located in ventral or dorsal primordia of the pancreatic head. Methods: From February 2016 to November 2018, 178 patients who underwent PD for PDAC were enrolled at the Pancreatic Disease Center, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University. According to the tumor location and the range of LN dissection, all patients were divided into three groups: ventral primordium with extended lymphadenectomy (VE group), ventral primordium with standard lymphadenectomy (VS group), and dorsal primordium with extended lymphadenectomy (DE group). Clinical and pathological features were retrospectively analyzed as were the long-term survival outcomes. Results: More patients in the VE group were detected with metastasis in the lymph nodes around the superior mesenteric artery (LN14) than those in the DE group (LN along the right side of the superior mesenteric artery, LN14ab): 22.9 vs. 5.9%, p = 0.005; (LN along the left side of the superior mesenteric artery, LN14cd): 10.0 vs. 0.0%, p = 0.022. LN14 was involved in more patients in the VE group than in the VS group (22.9 vs. 5.0%, p = 0.015). For IIb-stage patients in the VE group, the overall survival time (18.3 vs. 9.3 months, p < 0.001) and disease-free survival time (12.2 vs. 5.1 months, p = 0.045) were longer in those with LN14cd (–) than those with LN14cd (+). Conclusion: This study suggested that patients with PDAC located in the ventral head of the pancreas had higher risk of LN14 involvement compared with those at dorsal. Thus, a thorough dissection of LN14 in PDAC located in the ventral head of the pancreas is recommended to optimize the regional extended lymphadenectomy. Frontiers Media S.A. 2020-08-11 /pmc/articles/PMC7433687/ /pubmed/32850429 http://dx.doi.org/10.3389/fonc.2020.01343 Text en Copyright © 2020 Qian, Xie, Xu, Deng, Chen, Peng, Li, Chai, Xie, Wang and Shen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Qian, Lihan
Xie, Junjie
Xu, Zhiwei
Deng, Xiaxing
Chen, Hao
Peng, Chenghong
Li, Hongwei
Chai, Weimin
Xie, Jing
Wang, Weishen
Shen, Baiyong
The Necessity of Dissection of No. 14 Lymph Nodes to Patients With Pancreatic Ductal Adenocarcinoma Based on the Embryonic Development of the Head of the Pancreas
title The Necessity of Dissection of No. 14 Lymph Nodes to Patients With Pancreatic Ductal Adenocarcinoma Based on the Embryonic Development of the Head of the Pancreas
title_full The Necessity of Dissection of No. 14 Lymph Nodes to Patients With Pancreatic Ductal Adenocarcinoma Based on the Embryonic Development of the Head of the Pancreas
title_fullStr The Necessity of Dissection of No. 14 Lymph Nodes to Patients With Pancreatic Ductal Adenocarcinoma Based on the Embryonic Development of the Head of the Pancreas
title_full_unstemmed The Necessity of Dissection of No. 14 Lymph Nodes to Patients With Pancreatic Ductal Adenocarcinoma Based on the Embryonic Development of the Head of the Pancreas
title_short The Necessity of Dissection of No. 14 Lymph Nodes to Patients With Pancreatic Ductal Adenocarcinoma Based on the Embryonic Development of the Head of the Pancreas
title_sort necessity of dissection of no. 14 lymph nodes to patients with pancreatic ductal adenocarcinoma based on the embryonic development of the head of the pancreas
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433687/
https://www.ncbi.nlm.nih.gov/pubmed/32850429
http://dx.doi.org/10.3389/fonc.2020.01343
work_keys_str_mv AT qianlihan thenecessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT xiejunjie thenecessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT xuzhiwei thenecessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT dengxiaxing thenecessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT chenhao thenecessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT pengchenghong thenecessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT lihongwei thenecessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT chaiweimin thenecessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT xiejing thenecessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT wangweishen thenecessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT shenbaiyong thenecessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT qianlihan necessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT xiejunjie necessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT xuzhiwei necessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT dengxiaxing necessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT chenhao necessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT pengchenghong necessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT lihongwei necessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT chaiweimin necessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT xiejing necessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT wangweishen necessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas
AT shenbaiyong necessityofdissectionofno14lymphnodestopatientswithpancreaticductaladenocarcinomabasedontheembryonicdevelopmentoftheheadofthepancreas